ARCHIVES

Texas Oncology Designated Aranesp As Preferred Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 46 | December 13, 2002

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities Listed.

January 7, 2005

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

May 11, 2007

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010

UCLA Makes Members Compete For Space In Jonsson Center

August 3, 1990

In Brief: Allegheny Wins NSABP Recompetition; Luri Cancer Center Hosts Princess Diana

June 14, 1996

Senate Defeats Attempt To Cut NIH Funds

July 8, 1977